| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||
Net income (loss) | |||||||||
-357,304 | -603,573 | -559,000 | -178,143 | -377,707 | -201,303 | -180,973 | 0 | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||||||
Depreciation and amortization | |||||||||
216,450 | 207,235 | 200,425 | 190,080 | 171,520 | 137,403 | 0 | 0 | 0 | - |
Amortization of Levothyroxine Transition Agreement asset | |||||||||
0 | 36,393 | 46,816 | 46,816 | 46,816 | 10,423 | 0 | 0 | 0 | - |
Unrealized foreign currency loss | |||||||||
-6,366 | -7,342 | -7,574 | 2,145 | -33,399 | -18,582 | 0 | 0 | 0 | - |
Amortization of debt issuance costs and discount | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Amortization of debt issuance costs | |||||||||
- | - | - | - | - | 6,000 | 0 | 0 | 0 | - |
Gain on sale of international business | |||||||||
-1,560 | 7,258 | 6,784 | 3,972 | 5,860 | -2,958 | 0 | 0 | 0 | - |
Intangible asset impairment charges | |||||||||
99,113 | 172,781 | 197,210 | 126,170 | 123,158 | 47,074 | 0 | 0 | 0 | - |
Deferred tax benefit | |||||||||
381,600 | 371,716 | 371,355 | -12,655 | -18,811 | -9,439 | 0 | 0 | 0 | - |
Stock-based compensation | |||||||||
21,871 | 21,679 | 20,272 | 17,767 | 171,944 | 167,597 | 0 | 0 | 0 | - |
Inventory provision | |||||||||
81,795 | 82,245 | 91,628 | 77,523 | 57,344 | 44,539 | 0 | 0 | 0 | - |
Other operating charges and credits, net | |||||||||
-7,466 | -7,309 | -6,034 | -362 | -2,674 | 1,866 | 0 | 0 | 0 | - |
Changes in assets and liabilities: | |||||||||
Trade accounts receivable, net | |||||||||
28,607 | 132,726 | -117,338 | 13,819 | 80,909 | -89,084 | 0 | 0 | 0 | - |
Inventories | |||||||||
8,991 | 20,393 | 14,219 | -9,976 | 8,612 | 42,021 | 0 | 0 | 0 | - |
Income taxes receivable associated with the CARES Act | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Prepaid expenses, other current assets and other assets | |||||||||
10,170 | -38,870 | -40,228 | -42,496 | -29,941 | -8,775 | 0 | 0 | 0 | - |
Related party receivables | |||||||||
549 | 939 | 1,205 | 1,713 | -5,399 | -10,928 | 0 | 0 | 0 | - |
Accounts payable, accrued expenses and other liabilities | |||||||||
23,887 | -10,257 | -40,621 | -86,715 | -68,177 | -53,547 | 0 | 0 | 0 | - |
Related party payables | |||||||||
8,267 | 5,228 | 37 | 1,468 | -2,915 | -14,113 | 0 | 0 | 0 | - |
Other current assets and current liabilities | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by (used in) operating activities | |||||||||
159,141 | 1,705 | 312,245 | 234,464 | 114,791 | 250,230 | -9,421 | 0 | 0 | 0 |
Cash flows from investing activities: | |||||||||
Purchases of property, plant and equipment | |||||||||
36,560 | 47,181 | 62,687 | 76,117 | 81,577 | 83,088 | 0 | 0 | 0 | - |
Acquisition of intangible assets | |||||||||
51,300 | 50,250 | 50,000 | 61,000 | 9,000 | 14,000 | 0 | 0 | 0 | - |
Acquisitions, net of cash acquired | |||||||||
253,625 | 0 | 0 | 0 | 0 | - | - | - | - | - |
Cash sold with international business | |||||||||
0 | - | - | - | 0 | - | - | - | 0 | - |
Net cash used in investing activities | |||||||||
-260,156 | -19,580 | -9,492 | -80,249 | -398,345 | -396,378 | -401,699 | 0 | 0 | 0 |
Cash flows from financing activities: | |||||||||
Proceeds from issuance of debt | |||||||||
180,000 | 0 | 0 | 0 | 0 | - | - | - | - | - |
Payments of principal on debt and financing leases | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Payments of principal on debt and capital leases | |||||||||
- | - | - | - | - | 617,051 | 0 | 0 | 0 | - |
Net borrowings on revolving credit facility | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Payments of deferred financing costs | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Proceeds from exercise of stock options | |||||||||
395 | 1,400 | 2,020 | 3,205 | 4,807 | 3,797 | 0 | 0 | 0 | - |
Employee payroll tax withholding on restricted stock unit vesting | |||||||||
1,429 | 926 | 0 | 0 | 0 | - | - | - | - | - |
Capital contribution from non-controlling interest | |||||||||
- | - | - | - | - | 360 | 0 | 0 | 0 | - |
Acquisition of non-controlling interest | |||||||||
- | - | - | - | - | - | 0 | 0 | 0 | - |
Acquisition of non-controlling interest | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Tax distribution to non-controlling interest | |||||||||
0 | 13,494 | 49,037 | 49,037 | 49,037 | 35,543 | 0 | 0 | 0 | - |
Distributions to members | |||||||||
- | - | - | - | - | 183,000 | 0 | 0 | 0 | - |
Net cash provided by (used in) financing activities | |||||||||
444,010 | -45,833 | -257,455 | -167,259 | 299,057 | 287,675 | 506,595 | 0 | 0 | 0 |
Effect of foreign exchange rate on cash | |||||||||
-2,813 | -2,249 | -433 | 1,476 | -1,377 | -670 | 0 | 0 | 0 | - |
Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||||||
340,182 | -65,957 | 44,865 | -11,568 | 14,126 | 140,857 | 94,271 | 0 | 0 | 0 |
Supplemental disclosure of cash flow information: | |||||||||
Cash paid for interest | |||||||||
153,922 | 158,568 | 164,302 | 162,217 | 152,694 | 131,505 | 0 | 0 | 0 | - |
Cash (paid) received for income taxes, net | |||||||||
-2,888 | 10,255 | 52,188 | 43,485 | 46,175 | 34,952 | 0 | 0 | 0 | - |
Supplemental disclosure of non-cash investing and financing activity: | |||||||||
Receivable from the sale of international business | |||||||||
0 | - | - | - | 0 | - | - | - | 0 | - |
Payable for acquisition of product rights and licenses | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Related Party | |||||||||
Payments of principal on financing obligation - related party | |||||||||
- | - | - | - | - | - | - | 0 | 0 | - |
Payments of principal on financing lease - related party | |||||||||
1,914 | 2,270 | 0 | 0 | 0 | - | - | - | - | - |
Notes payable for acquisitions - related party | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |